Viewing nowCombinationAtovaef Tablet 10/10 mg
Ezetimibe 10mg · Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication · Combination
Daehwa Pharmaceutical Co., Ltd.

MFDS item code 202101518 · Approved 2021.02.18 · Insurance code 645605510
Treatment of hypercholesterolemia (primary and homozygous familial) and mixed dyslipidemia
This medication is used in conjunction with diet to lower total cholesterol, LDL cholesterol, Apo B, triglycerides, and non-HDL cholesterol levels in patients with primary hypercholesterolemia, especially those with heterozygous familial and non-familial types, and to increase HDL cholesterol levels. It can also be used as an adjunct therapy to reduce total cholesterol and LDL cholesterol in patients with homozygous familial hypercholesterolemia and can be administered when other treatments are not feasible. This medication is used along with appropriate dietary guidelines in patients at high risk for cardiovascular diseases and assists in improving vascular health through lipid control. Before taking this medication, secondary causes such as diabetes and hypothyroidism should be checked and treated if necessary. This medication contributes to reducing the risk of atherosclerotic vascular diseases due to hypercholesterolemia.
Administer this medicine once daily, with or without food. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dose range is 10/10 mg to 10/80 mg once daily. The recommended starting dose is 10/10 mg or 10/20 mg once daily. For patients who require a greater reduction in LDL cholesterol (55% or more), a starting dose of 10/40 mg once daily is recommended. After starting treatment or adjusting the dose, check blood lipid levels at intervals of at least 2 weeks and adjust the dose accordingly. Homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40 mg or 10/80 mg once daily. This medicine should be administered as an adjunct to other lipid-lowering therapies (e.g., LDL apheresis) or when other lipid-lowering therapies are not useful.
This medication can rarely cause muscle tissue damage, leading to muscle pain or weakness; in severe cases, it can result in a serious condition called rhabdomyolysis. Due to the risk of rapid deterioration of kidney function, treatment should be discontinued immediately, and a doctor should be consulted if severe myopathy symptoms occur. Additionally, it can affect liver function, so liver function tests should be performed regularly before and during treatment. This medication should not be administered to patients with certain liver diseases or those with abnormally high liver enzyme levels. Women who are pregnant, likely to become pregnant, or breastfeeding should not take this medication. There may be interactions when taken with other medications, so any medications currently being taken should be disclosed to healthcare providers. Special caution is needed when taken with medications that affect liver function or may increase muscle toxicity. Symptoms such as dizziness, muscle pain, or abdominal pain may occur, and if these symptoms persist or worsen, a doctor should be informed. Elderly patients or those with impaired kidney function should also exercise caution when taking this medication, and thorough consultation with a healthcare provider is recommended before taking it. It is advisable to avoid alcohol consumption during the treatment, and regular blood tests and clinical monitoring are recommended.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 to 30 degrees Celsius.
White oblong film-coated tablet
30 tablets/box[(10 tablets/PTP x3)], 30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication · Combination
Daehwa Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 86.8mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 10.9mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationAtorvastatin Calcium 10.85mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
CombinationAtorvastatin Calcium 21.7mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
CombinationAtorvastatin Calcium 43.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.